NCT05960890Recruiting
Cohort Study of Chronic Heart Failure
Source: ClinicalTrials.gov · Last updated 20 May 2026
Brief summary (registry, in English)
The goal of this observational study is to learn about the influencing factors of chronic heart failure prognosis in heart failure patients. The main question it aims to answer is that what are the influencing factors of clinical outcomes in chronic heart failure. Participants will be collected multiple omics data such as phenotype group, environmental exposure group, intestinal microbiome, genome, metabolome, and noninvasive biomarkers.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 1000 (estimated)
- First submitted
- 7 Jul 2023
- Start date
- 8 Jun 2023
- Primary completion date
- 31 Dec 2028
- Lead sponsor
- Jiangsu Taizhou People's Hospital
- Diseases
- Heart failure
- NCT number
- NCT05960890
What you commit to
- Study type: Interventional
- Planned participants: 1000
- From 8 Jun 2023 to the primary completion date, 31 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with indications for pacemaker implantation but have not received a pacemaker implant;
Other illness
- Patients with renal failure (Ccr\<30ml/min) or patients on dialysis therapy;
- Various correctable secondary causes of cardiac insufficiency including hyperthyroid heart disease, anaemic heart disease, uncorrected congenital heart disease; severe valvular heart disease (including severe stenosis or closure of organic aortic and mitral valves);
- Patients with chronic obstructive pulmonary disease accompanied by type II respiratory failure.
- Patients with mental illness, pregnant women, and other special populations.
Other
- Patients who cannot understand and sign an informed consent form.
Who the study is looking for
- Age ≥18 years;
- Fulfill at least one of the following criteria：①History of chronic heart failure;②New-onset heart failure with LVEF \<50%；③New-onset heart failure with LVEF≧50%，E/e'≧15 and BNP\>400 pg/mL/NT-proBNP(\<50 years, \>450 pg/mL; 50\~75 years, \>900 pg/mL; \>75 years, \>1800 pg/mL)
- Etiology: dilated cardiomyopathy, hypertensive heart disease, ischaemic cardiomyopathy, Non-severe valvular heart disease；
- Primary post-discharge therapy: oral medication;
- Sign the informed consent form.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Taizhou People's Hospital affiliated to Nanjing Medical University Coordinator of this site? Confirm its status | Taizhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.